• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 RGD 修饰的生物可还原聚合物用于递送表达抗 IL-8mRNA 的 shRNA 的溶瘤腺病毒。

Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.

机构信息

Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84112, USA.

出版信息

Biomaterials. 2011 Aug;32(22):5158-66. doi: 10.1016/j.biomaterials.2011.03.084. Epub 2011 Apr 30.

DOI:10.1016/j.biomaterials.2011.03.084
PMID:21531456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3100416/
Abstract

Even though oncolytic adenovirus (Ad) has been highlighted in the field of cancer gene therapy, transductional targeting and immune privilege still remain difficult challenges. The recent reports have noted the increasing tendency of adenoviral surface shielding with polymer to overcome the limits of its practical application. We previously reported the potential of the biodegradable polymer, poly(CBA-DAH) (CD) as a promising candidate for efficient gene delivery. To endow the selective-targeting moiety of tumor vasculature to CD, cRGDfC well-known as a ligand for cell-surface integrins on tumor endothelium was conjugated to CD using hetero-bifunctional cross-linker SM (PEG)(n). The cytopathic effects of oncolytic Ad coated with the polymers were much more enhanced dose-dependently when compared with that of naked Ad in cancer cells selectively. Above all, the most potent oncolytic effect was assessed with the treatment of Ad/CD-PEG(500)-RGD in all cancer cells. The enhanced cytopathic effect of Ad/RGD-conjugated polymer was specifically inhibited by blocking antibodies to integrins, but not by blocking antibody to CAR. HT1080 cells treated with Ad/CD-PEG(500)-RGD showed strong induction of apoptosis and suppression of IL-8 and VEGF expression as well. These results suggest that RGD-conjugated bioreducible polymer might be used to deliver oncolytic Ad safely and efficiently for tumor therapy.

摘要

尽管溶瘤腺病毒(Ad)在癌症基因治疗领域备受关注,但转导靶向和免疫豁免仍然是难以克服的挑战。最近的报告指出,通过聚合物对腺病毒表面进行遮蔽,以克服其实际应用的限制,这种趋势越来越明显。我们之前曾报道过可生物降解聚合物聚(CBA-DAH)(CD)作为高效基因传递的有前途的候选物的潜力。为了将肿瘤血管的选择性靶向部分赋予 CD,将 cRGDfC(一种已知的肿瘤内皮细胞表面整合素的配体)用杂双功能交联剂 SM(PEG)(n)连接到 CD 上。与裸 Ad 相比,用聚合物包裹的溶瘤 Ad 在癌细胞中具有更强的剂量依赖性细胞病变效应。最重要的是,在用 Ad/CD-PEG(500)-RGD 处理所有癌细胞时,评估了最强的溶瘤作用。Ad/RGD 偶联聚合物的增强细胞病变效应可被整合素阻断抗体特异性抑制,但不能被 CAR 阻断抗体抑制。用 Ad/CD-PEG(500)-RGD 处理的 HT1080 细胞表现出强烈的诱导凋亡和抑制 IL-8 和 VEGF 表达的作用。这些结果表明,RGD 偶联的生物还原聚合物可用于安全有效地传递溶瘤腺病毒进行肿瘤治疗。

相似文献

1
Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.靶向 RGD 修饰的生物可还原聚合物用于递送表达抗 IL-8mRNA 的 shRNA 的溶瘤腺病毒。
Biomaterials. 2011 Aug;32(22):5158-66. doi: 10.1016/j.biomaterials.2011.03.084. Epub 2011 Apr 30.
2
Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.用于癌症基因治疗的、与溶瘤腺病毒复合的、肝癌靶向肽偶联生物可还原聚合物
J Control Release. 2015 Dec 28;220(Pt B):691-703. doi: 10.1016/j.jconrel.2015.09.068. Epub 2015 Oct 3.
3
Therapeutic efficacy of a systemically delivered oncolytic adenovirus - biodegradable polymer complex.系统递送溶瘤腺病毒-可生物降解聚合物复合物的治疗效果。
Biomaterials. 2013 Jun;34(19):4622-31. doi: 10.1016/j.biomaterials.2013.03.004. Epub 2013 Mar 27.
4
Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer.靶向整合素 RGD 的生物可还原聚合物复合物对成瘤性腺病毒的肺原位肿瘤生长的高效抑制作用。
Gene Ther. 2014 May;21(5):476-83. doi: 10.1038/gt.2014.18. Epub 2014 Mar 6.
5
Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus.双肿瘤靶向 pH 敏感和生物可还原聚合物复合溶瘤腺病毒。
Biomaterials. 2015 Feb;41:53-68. doi: 10.1016/j.biomaterials.2014.11.021. Epub 2014 Dec 5.
6
Oncolytic Adenovirus Coated with Multidegradable Bioreducible Core-Cross-Linked Polyethylenimine for Cancer Gene Therapy.多降解型生物还原核交联聚乙烯亚胺包被的溶瘤腺病毒用于癌症基因治疗。
Biomacromolecules. 2015 Jul 13;16(7):2132-43. doi: 10.1021/acs.biomac.5b00538. Epub 2015 Jun 29.
7
VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.表达VEGF特异性短发夹RNA的溶瘤腺病毒可有效抑制血管生成和肿瘤生长。
Mol Ther. 2007 Feb;15(2):295-302. doi: 10.1038/sj.mt.6300023.
8
pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis.靶向酸性肿瘤微环境和血管生成的pH敏感型溶瘤腺病毒杂交体
J Control Release. 2015 May 10;205:134-43. doi: 10.1016/j.jconrel.2015.01.005. Epub 2015 Jan 7.
9
Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.神经降压素受体靶向共表达decorin 和 Wnt 拮抗剂的溶瘤腺病毒在原位胰腺肿瘤模型中的强效抗肿瘤作用。
J Control Release. 2015 Dec 28;220(Pt B):766-82. doi: 10.1016/j.jconrel.2015.10.015. Epub 2015 Oct 22.
10
Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model.生物可还原聚合物包被的溶瘤腺病毒治疗CAR阴性肿瘤模型的安全性及抗肿瘤疗效
Biomacromolecules. 2015 Jan 12;16(1):87-96. doi: 10.1021/bm501116x. Epub 2014 Dec 1.

引用本文的文献

1
Surface Functionalized Polyhydroxyalkanoate Nanoparticles via SpyTag-SpyCatcher System for Targeted Breast Cancer Treatment.通过SpyTag-SpyCatcher系统实现表面功能化的聚羟基脂肪酸酯纳米颗粒用于靶向乳腺癌治疗
Pharmaceutics. 2025 May 29;17(6):721. doi: 10.3390/pharmaceutics17060721.
2
Emerging delivery strategy for oncolytic virotherapy.溶瘤病毒疗法的新兴递送策略。
Mol Ther Oncol. 2024 Apr 29;32(2):200809. doi: 10.1016/j.omton.2024.200809. eCollection 2024 Jun 20.
3
Progress in oncolytic viruses modified with nanomaterials for intravenous application.纳米材料修饰的溶瘤病毒在静脉给药方面的研究进展。
Cancer Biol Med. 2023 Nov 24;20(11):830-55. doi: 10.20892/j.issn.2095-3941.2023.0275.
4
NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review.基于 NGR 的放射性药物用于血管生成显像的临床前评价。
Int J Mol Sci. 2023 Aug 11;24(16):12675. doi: 10.3390/ijms241612675.
5
Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications.用于核酸递送的非病毒载体:基础与当前应用
Life (Basel). 2023 Mar 29;13(4):903. doi: 10.3390/life13040903.
6
Challenges and progress toward tumor-targeted therapy by systemic delivery of polymer-complexed oncolytic adenoviruses.通过全身递送聚合物复合溶瘤腺病毒进行肿瘤靶向治疗的挑战与进展。
Cancer Gene Ther. 2022 Oct;29(10):1321-1331. doi: 10.1038/s41417-022-00469-y. Epub 2022 Apr 20.
7
Polymeric Systems for Cancer Immunotherapy: A Review.聚合物系统在癌症免疫治疗中的应用:综述。
Front Immunol. 2022 Feb 22;13:826876. doi: 10.3389/fimmu.2022.826876. eCollection 2022.
8
Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials.用于设计功能性细胞响应生物材料的整合素靶向肽
Biomedicines. 2020 Aug 25;8(9):307. doi: 10.3390/biomedicines8090307.
9
p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy.p53-Bad:一种新型肿瘤抑制因子/促凋亡因子杂合体,靶向线粒体,用于卵巢癌基因治疗。
Mol Pharm. 2019 Aug 5;16(8):3386-3398. doi: 10.1021/acs.molpharmaceut.9b00136. Epub 2019 Jun 26.
10
Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX.血友病 B 的自体和异体细胞治疗:实现因子 IX 的功能恢复。
Cell Rep. 2018 May 1;23(5):1565-1580. doi: 10.1016/j.celrep.2018.03.121.

本文引用的文献

1
Current advances in adenovirus nanocomplexes: more specificity and less immunogenicity.腺病毒纳米复合物的最新进展:提高特异性,降低免疫原性。
BMB Rep. 2010 Dec;43(12):781-8. doi: 10.5483/BMBRep.2010.43.12.781.
2
Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium.心肌细胞靶向型生物可还原聚合物用于高效递送至心肌的基因治疗。
Biomaterials. 2010 Nov;31(31):8081-7. doi: 10.1016/j.biomaterials.2010.07.025. Epub 2010 Jul 31.
3
Combination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transduction.腺病毒与交联的低分子量 PEI 联合提高基因转导效率。
Nanotechnology. 2010 Mar 12;21(10):105106. doi: 10.1088/0957-4484/21/10/105106. Epub 2010 Feb 15.
4
HPMA copolymers for masking and retargeting of therapeutic viruses.用于掩蔽和重定向治疗性病毒的 HPMA 共聚物。
Adv Drug Deliv Rev. 2010 Feb 17;62(2):240-5. doi: 10.1016/j.addr.2009.12.003. Epub 2009 Dec 29.
5
The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy.精氨酸接枝的生物可还原聚合物对腺病毒表面修饰对癌症基因治疗中转导效率和免疫原性的影响。
Biomaterials. 2010 Mar;31(7):1865-74. doi: 10.1016/j.biomaterials.2009.11.043. Epub 2009 Dec 3.
6
HPMA copolymer-cyclic RGD conjugates for tumor targeting.HPMA 共聚物-环 RGD 缀合物用于肿瘤靶向。
Adv Drug Deliv Rev. 2010 Feb 17;62(2):167-83. doi: 10.1016/j.addr.2009.11.027. Epub 2009 Dec 4.
7
Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation.聚合物转染的原代成肌细胞介导有效的基因表达和血管生成增殖。
J Control Release. 2010 Feb 25;142(1):61-9. doi: 10.1016/j.jconrel.2009.09.021. Epub 2009 Oct 7.
8
Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking.具有环状RGD肽配体和二硫键交联的多聚体胶束,通过可控的细胞内运输实现增强转染。
Mol Pharm. 2008 Nov-Dec;5(6):1080-92. doi: 10.1021/mp800070s.
9
Nonviral vectors for gene delivery.用于基因递送的非病毒载体。
Chem Rev. 2009 Feb;109(2):259-302. doi: 10.1021/cr800409e.
10
Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems.用于基因递送系统的精氨酸接枝生物可还原聚(二硫代胺)
Biomaterials. 2009 Feb;30(4):658-64. doi: 10.1016/j.biomaterials.2008.10.009. Epub 2008 Nov 12.